 21995387|breast|C0006141^C1268990|start=0|end=6|ANAT
 21995387|cancer|C0006826^C1547140^C1306459^C2707253|start=7|end=13|DISO^OCCU^PHYS
 21995387|adjuvant therapy|C0677850|start=14|end=30|PROC
 21995387|acid|C0202406|start=47|end=51|PROC
 21995387|background|C1706907|start=53|end=63|CONC
 21995387|data|C3245479^C1511726|start=65|end=69|DEVI^CONC
 21995387|suggest|C1705535|start=70|end=77|CONC
 21995387|adjuvant|C1522673|start=87|end=95|CONC
 21995387|use of|C1524063|start=96|end=102|CONC
 21995387|recurrence|C1458156^C0034897^C2825055|start=136|end=146|DISO^PHEN
 21995387|death|C1546949^C0011065|start=151|end=156|PHYS^CONC
 21995387|early-stage breast cancer|C2986665|start=174|end=199|DISO
 21995387|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=216|end=221|PROC^OBJC^CONC
 21995387|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=243|end=252|PROC^CONC
 21995387|acid|C0202406|start=269|end=273|PROC
 21995387|in addition to|C0332287|start=275|end=289|CONC
 21995387|standard|C1548173^C1442989^C2828392^C3272550|start=290|end=298|CONC
 21995387|adjuvant therapy|C0677850|start=299|end=315|PROC
 21995387|disease|C0012634|start=331|end=338|DISO
 21995387|methods|C0025664^C0449851^C0025663|start=366|end=373|CONC
 21995387|phase 3 study|C0282461|start=394|end=407|PROC
 21995387|assigned|C1552601^C1516050|start=421|end=429|CONC
 21995387|receive|C1514756|start=447|end=454|CONC
 21995387|standard|C1548173^C1442989^C2828392^C3272550|start=455|end=463|CONC
 21995387|adjuvant|C1522673|start=464|end=472|CONC
 21995387|systemic therapy|C1515119|start=473|end=489|PROC
 21995387|acid|C0202406|start=524|end=528|PROC
 21995387|acid|C0202406|start=545|end=549|PROC
 21995387|administered|C1521801|start=554|end=566|CONC
 21995387|4 weeks|C1442465|start=578|end=585|CONC
 21995387|doses|C0178602|start=592|end=597|CONC
 21995387|months|C0439231|start=620|end=626|CONC
 21995387|complete|C1548561^C0205197^C1706059|start=630|end=638|CONC
 21995387|years|C0439234|start=641|end=646|CONC
 21995387|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=650|end=659|PROC^CONC
 21995387|primary|C0205225^C0439631|start=665|end=672|PROC^CONC
 21995387|end point|C2349179|start=673|end=682|CONC
 21995387|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=690|end=695|PROC^OBJC^CONC
 21995387|disease-free survival|C0242793|start=700|end=721|CONC
 21995387|second|C0205436^C1561503^C0457385^C1705190^C2348168|start=725|end=731|CONC
 21995387|interim|C2827738|start=732|end=739|CONC
 21995387|analysis|C1524024^C0936012^C0002778|start=740|end=748|PROC^CONC
 21995387|revealed|C0443289|start=749|end=757|CONC
 21995387|lack|C0332268|start=791|end=795|CONC
 21995387|benefit|C0814225|start=799|end=806|CONC
 21995387|crossed|C0205203|start=816|end=823|CONC
 21995387|median|C0876920^C2347635^C2939193^C0549183^C2348144|start=839|end=845|CONC
 21995387|follow-up|C1704685^C1522577^C3274571|start=846|end=855|PROC^CONC
 21995387|months|C0439231|start=862|end=868|CONC
 21995387|significant|C0750502^C1546944^C0237881|start=883|end=894|CONC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=903|end=908|ORGA^CONC
 21995387|difference|C1705242^C1705241|start=909|end=919|CONC
 21995387|primary|C0205225^C0439631|start=927|end=934|PROC^CONC
 21995387|end point|C2349179|start=935|end=944|CONC
 21995387|rate|C1521828^C0871208^C1549480|start=953|end=957|ACTI^CONC
 21995387|disease-free survival|C0242793|start=961|end=982|CONC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=998|end=1003|ORGA^CONC
 21995387|adjusted|C0456081|start=1005|end=1013|CONC
 21995387|hazard ratio|C2985465|start=1014|end=1026|CONC
 21995387|acid|C0202406|start=1045|end=1049|PROC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1050|end=1055|ORGA^CONC
 21995387|confidence interval|C0009667|start=1067|end=1086|CONC
 21995387|disease|C0012634|start=1116|end=1123|DISO
 21995387|recurrence|C1458156^C0034897^C2825055|start=1124|end=1134|DISO^PHEN
 21995387|death|C1546949^C0011065|start=1138|end=1143|PHYS^CONC
 21995387|occurred|C1709305|start=1144|end=1152|ACTI
 21995387|acid|C0202406|start=1187|end=1191|PROC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1192|end=1197|ORGA^CONC
 21995387|control|C1547100^C0243148^C3274648^C2587213^C1882979^C1550141|start=1222|end=1229|OBJC^CONC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1230|end=1235|ORGA^CONC
 21995387|numbers|C0449788^C0237753|start=1241|end=1248|CONC
 21995387|deaths|C0011065|start=1252|end=1258|PHYS
 21995387|acid|C0202406|start=1282|end=1286|PROC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1287|end=1292|ORGA^CONC
 21995387|control|C1547100^C0243148^C3274648^C2587213^C1882979^C1550141|start=1308|end=1315|OBJC^CONC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1316|end=1321|ORGA^CONC
 21995387|similar|C2348205|start=1333|end=1340|CONC
 21995387|resulting in|C0332294|start=1342|end=1354|CONC
 21995387|survival|C0038952^C0220921|start=1372|end=1380|ACTI^CONC
 21995387|acid|C0202406|start=1408|end=1412|PROC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1413|end=1418|ORGA^CONC
 21995387|control|C1547100^C0243148^C3274648^C2587213^C1882979^C1550141|start=1436|end=1443|OBJC^CONC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1444|end=1449|ORGA^CONC
 21995387|adjusted|C0456081|start=1451|end=1459|CONC
 21995387|hazard ratio|C2985465|start=1460|end=1472|CONC
 21995387|acid|C0202406|start=1529|end=1533|PROC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1534|end=1539|ORGA^CONC
 21995387|confirmed|C0521093^C0750484|start=1555|end=1564|CONC
 21995387|cases|C1533148^C0868928|start=1565|end=1570|CONC
 21995387|osteonecrosis|C0029445^C0520474|start=1574|end=1587|DISO
 21995387|jaw|C1706308^C0024687^C0022359^C1273020|start=1595|end=1598|DEVI^ANAT
 21995387|cumulative|C1511559|start=1600|end=1610|CONC
 21995387|incidence|C0220856^C0021149|start=1611|end=1620|CONC
 21995387|suspected|C0750491|start=1663|end=1672|CONC
 21995387|cases|C1533148^C0868928|start=1673|end=1678|CONC
 21995387|cases|C1533148^C0868928|start=1694|end=1699|CONC
 21995387|control|C1547100^C0243148^C3274648^C2587213^C1882979^C1550141|start=1707|end=1714|OBJC^CONC
 21995387|group|C1552516^C1561557^C1705428^C0441833|start=1715|end=1720|ORGA^CONC
 21995387|adverse effects|C0879626^C0001688|start=1737|end=1752|DISO^CONC
 21995387|similar|C2348205|start=1758|end=1765|CONC
 21995387|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=1777|end=1782|PROC^OBJC^CONC
 21995387|groups|C1552839^C0441833|start=1783|end=1789|CONC
 21995387|conclusions|C1707478|start=1791|end=1802|CONC
 21995387|findings|C2607943^C2926606^C3539655|start=1810|end=1818|PHYS^CONC
 21995387|support|C0183683^C1521721^C1317973^C0344211|start=1826|end=1833|PROC^PHYS^DEVI^CONC
 21995387|routine|C1547582^C0205547^C1546438^C1546402^C1561591^C1547137^C1548424^C1549563|start=1838|end=1845|CONC
 21995387|use of|C1524063|start=1846|end=1852|CONC
 21995387|acid|C0202406|start=1864|end=1868|PROC
 21995387|adjuvant|C1522673|start=1876|end=1884|CONC
 21995387|management|C1273870^C3273539^C0376636^C0001554|start=1885|end=1895|OCCU^PROC^ACTI
 21995387|breast cancer|C0006142^C0678222|start=1899|end=1912|DISO
 21995387|funded|C0016820|start=1915|end=1921|CONC
 21995387|pharmaceuticals|C1135440|start=1934|end=1949|PROC
 21995387|national|C3245503^C0015737|start=1958|end=1966|ORGA^CONC
 21995387|cancer research network|C1516224|start=1967|end=1990|ORGA
 21995387|current|C1705970^C0521116|start=1998|end=2005|PHEN^CONC
 21995387|controlled|C2587213|start=2006|end=2016|CONC
 21995387|number|C1554106^C0449788^C0237753|start=2024|end=2030|CONC
